gdc

Leukemia

A Look at COVID-19 Vaccination in Patients with Chronic Lymphocytic Leukemia
CLL Monthly MinutesLeukemia
It is recommended that most patients with CLL receive the COVID-19 vaccine, although each patient should still talk with their healthcare team first.
Predicting Which Patients with Chronic Lymphocytic Leukemia Might Need Early Treatment
CLL Monthly MinutesLeukemia
A new laboratory-based scoring system may allow physicians to better predict which patients with early-stage CLL are most likely to require early treatment.
Evaluating the Risk of Severe COVID-19 in Patients with Chronic Lymphocytic Leukemia
CLL Monthly MinutesLeukemia
Patients with CLL may be at increased risk for developing severe COVID-19. Experts have provided insights on how to protect them while still delivering optimal care.
Zanubrutinib Now Recommended for Certain Patients with Chronic Lymphocytic Leukemia
CLL Monthly MinutesLeukemia
Updated National Comprehensive Cancer Network (NCCN) guidelines now recommend zanubrutinib as alternative first- and second-line therapy for some patients.
A Look at Cannabis Extracts for Patients with Chronic Lymphocytic Leukemia
CLL Monthly MinutesLeukemia
Cannabis compounds such as cannabidiol have shown cancer-fighting activity in the lab. What should patients know?
Moving Toward a Better Understanding of the Chronic Lymphocytic Leukemia Patient Experience
CLL Monthly MinutesLeukemia
A new model of the symptoms and impacts faced by patients may lead to better clinical tools for understanding the patient experience.
Watchful Waiting with Chronic Lymphocytic Leukemia
CLL Monthly MinutesLeukemia
Patients who are in a period of active observation should feel comfortable sharing anything that seems abnormal with their healthcare provider.
The Impact of Comorbid Health Conditions on Survival in Chronic Lymphocytic Leukemia
CLL Monthly MinutesLeukemia
A greater number of comorbidities alone may not be sufficient to predict patient survival; age and stage at diagnosis must be considered as well.
Acalabrutinib Shown to Be as Effective as Ibrutinib in Chronic Lymphocytic Leukemia with Less Atrial Fibrillation
CLL Monthly MinutesLeukemia
The first phase 3 trial comparing these drugs shows that acalabrutinib has similar efficacy as ibrutinib with a lower risk of a worrisome side effect.
The Impact of COVID-19 on Patient–Doctor Communication
CLL Monthly MinutesLeukemia
Although the use of telemedicine has been increasing due to the COVID-19 pandemic, it has not completely replaced the need for in-person visits.
Page 1 of 10
Results 1 - 10 of 94

Subscribe to CONQUER: the patient voice magazine

Receive timely cancer news & updates, patient stories, and more.

Country